Hammersmith Medicines Research Ltd logo

Hammersmith Medicines Research Ltd

Specialists in clinical pharmacology, phase 1 and early phase 2 trials

267 employees · est. 1993

VS
Profil logo

Profil

We are the leading institute for early phase diabetes and obesity clinical trials.

222 employees · est. 1999 · Neuss, Germany

Hammersmith Medicines Research Ltd is the older company (1993 vs 1999).

Side-by-Side Comparison

Hammersmith Medicines Research Ltd Profil
Founded
1993 older 1999
Headquarters
Not tracked yet Neuss, Germany
Employees
267 222
Industry
Biotechnology, Health Care, Pharmaceutical Health Care
Funding Stage
Grant Not tracked yet
Total Funding
$50.00K Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Not tracked yet Clinical Trial Services, Patient Recruitment, Data Management, Regulatory Handling, Clinical Development Consulting
Target Customers
Not tracked yet Pharmaceutical Companies, Biotechnology Firms, Medical Device Companies, Academic Research Institutions
Taxonomy
Clinical Pharmacology, Phase 1 Trials, Early Phase 2 Trials, Contract Research Organisation (CRO), Clinical Trials, Pharmacokinetic Studies, Pharmacodynamic Studies, Safety And Tolerability Testing, Sleep Studies, Metabolic Studies, Drug Interactions, Pharmacy Services, Aseptic Unit, Radiopharmacy, Clinical Research Diabetes Clinical Trials, Metabolic Disease Research, Pharmacodynamic Studies, Glucose Clamp Studies, Regulatory Affairs In Clinical Research, GMP-Certified Pharmacy, Early Phase Trials, Isotope Dilution Techniques, Obesity Research, Pharmacology Expertise, Endocrinology Research, Clinical Data Management, Biopsies In Clinical Trials, PK/PD Modelling, Cardiology In Metabolic Diseases
Website
hmrlondon.com profil.com
Hammersmith Medicines Research Ltd logo

About Hammersmith Medicines Research Ltd

(HMR) is a Contract Research Organisation (CRO) specializing in clinical pharmacology, phase 1, and early phase 2 trials. With of spacious premises equipped with , a sleep unit for polysomnography, volunteer facilities, laboratories, pharmacy including an aseptic unit and radiopharmacy, and office...

Profil logo

About Profil

Profil GmbH is a specialized clinical research organization established in 1999 in Germany, focused on diabetes and related metabolic diseases. This focus distinguishes it from other CROs, offering sophisticated experimental methods, including glucose clamp studies and isotope dilution techniques, e...

We will tell you when either one moves

BounceWatch watches Hammersmith Medicines Research Ltd and Profil for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Hammersmith Medicines... and Profil — by email.

Frequently Asked Questions

Hammersmith Medicines Research Ltd — Specialists in clinical pharmacology, phase 1 and early phase 2 trials. Profil — We are the leading institute for early phase diabetes and obesity clinical trials.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Hammersmith Medicines Research Ltd has raised $50.00K while Profil has raised undisclosed funding.
Hammersmith Medicines Research Ltd and Profil operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Hammersmith Medicines Research Ltd with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Hammersmith Medicines Research Ltd on 6 Dec 2024, and Profil on 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes